Abstract
Objectives The Diamond Princess cruise ship is a unique case because it is the place at which testing capacity has reached its highest rate in the world during the COVID-19 pandemic. By analysing data that are collected about the current COVID-19 outbreak onboard, and by considering the design of the air conditioning system of the ship and virus transmission modes on cruise ships, this study aims to raise the hypothesis regarding the role of poor ventilation systems in the spread of COVID-19.
Design This is an analysis of count data that has been collected by the onboard clinic up to the 20th February 2020. Symptomatic infection rates during the quarantine period in cabins with previous confirmed cases are compared to these in cabins without previous confirmed cases.
Results Symptomatic infection rate during the quarantine period in cabins with previously confirmed cases is not significantly higher than that in cabins without previously confirmed cases. Age doesn’t appear to be a cofounder.
Conclusions Airborne transmission of COVID-19 through the ventilation system onboard could explain the virus spread into cabins during the quarantine period.
Strength and Limitations of the study
The study described an important intervention measure that is ignored by national authorities to reduce exposure and limit the transmission of COVID-19 in confined places.
The study reviewed the Diamond Princess cruise ship deck plans, the design of its HVAC (heating ventilation air-conditioning) system, and previous viral outbreaks on cruise ships.
The study considered all other studies that highlighted the airborne transmission mode of COVID-19.
The study only considered the airborne transmission mode to explain the infection with COVID-19 in passengers’ cabins on the Diamond Princess cruise ship.
The study used published count data to calculate the infection rates.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
formal Research Ethics approval was not required. Also, no patient and involved in this study
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No additional data available
https://www.niid.go.jp/niid/en/2019-ncov-e/9417-covid-dp-fe-02.html
